The 5 amino 1mq dose should be individualized based on body weight, metabolic goals, and individual response to treatment
Introduction into humans or animals is strictly prohibited
Its FDA-approved for reducing visceral adipose tissue, particularly in HIV-associated lipodystrophy, but its effects translate well for general fat loss in the abdominal region
Research has examined how NNMT may participate in such changes within adipose tissue
Methylcobalamin is less stable than cyanocobalamin and more sensitive to light degradation
However, some people may experience some pain, swelling or redness at the injection site, and in much rarer cases headaches, itching or nausea